SEC62 and prostate carcinoma: These results confirmed conclusions of previous studies reporting similar effects of SEC62 gene silencing on lung cancer, prostate cancer, fibrosarcoma, glioblastoma and thyroid cancer cell lines [15, 23], as well as effects of SEC62 overexpression on human embryonic kidney cells [24].